Double Blind Crossover Comparison of Diuretics in the Young
NCT00429897 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2007-02-01
Summary
The principle objective of the study is to determine whether low-renin (i.e. salt sensitive) hypertension at a young age is caused by the kidneys hanging onto too much salt as a result of an over active salt pump in the kidney.
The kidneys have four different salt pumps, and each is blocked by a different type of diuretic (salt losing tablet)If one out of the four is overactive, we would expect patients to respond much better to one diuretic than to the alternatives - rather than responding equally well to all available types of diuretic.
Conditions
- Low-Renin Hypertension
Interventions
- DRUG
-
Bendroflumethiazide 2.5mg - 5mg
- DRUG
-
Amiloride 20-40mg
- DRUG
-
Spironolactone 50-100mg
- DRUG
-
Frusemide 20-40mg
- DRUG
-
Bendroflumethiazide 1.25-2.5mg/ Amiloride 10-20mg combined
Sponsors & Collaborators
-
British Heart Foundation
collaborator OTHER - lead OTHER
Principal Investigators
-
Morris J Brown, Proffessor · Cambridge University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-08-31
- Completion
- 2007-07-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD
NCT02502981 ·Status: UNKNOWN ·Phase: PHASE4
-
Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency
NCT01172431 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients
NCT00690521 ·Status: COMPLETED ·Phase: NA
-
The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure
NCT04455178 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker
NCT00310778 ·Status: COMPLETED ·Phase: PHASE1
-
Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension
NCT02646397 ·Status: UNKNOWN ·Phase: PHASE4
-
Skin Sodium and Salt Sensitivity of Blood Pressure
NCT05976438 ·Status: UNKNOWN ·Phase: NA
-
Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy
NCT00125437 ·Status: TERMINATED ·Phase: NA
-
Spironolactone in Patients With Single Ventricle Heart
NCT00211081 ·Status: COMPLETED ·Phase: NA
-
Spironolactone Versus Amiloride as an Add on Agent in Resistant Hypertension
NCT00709137 ·Status: WITHDRAWN ·Phase: NA
-
Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure. AREA IN-CHF Study
NCT00403910 ·Status: COMPLETED ·Phase: PHASE3
-
Diuretic Comparison Project
NCT02185417 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanisms of Diuretic Resistance in Heart Failure, Aim 2
NCT05753059 ·Status: RECRUITING ·Phase: PHASE1
-
Immediate Release Torsemide Versus Extended Release Torsemide After Salty Meal
NCT06176794 ·Status: WITHDRAWN ·Phase: PHASE2
-
Cardiovascular Protective Effect of Spironolactone in Hemodialysis
NCT00277693 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Thiazide, Amiloride and Hypertonic Saline on Urinary Biomarkers in Healthy Subjects
NCT01635231 ·Status: COMPLETED ·Phase: NA
-
Study in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium
NCT03682497 ·Status: TERMINATED ·Phase: PHASE1
-
Chlorthalidone in Chronic Kidney Disease
NCT02841280 ·Status: COMPLETED ·Phase: PHASE2
-
Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease
NCT02497300 ·Status: COMPLETED ·Phase: PHASE2
-
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
NCT02235077 ·Status: COMPLETED ·Phase: PHASE2
-
Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
NCT05411991 ·Status: COMPLETED ·Phase: PHASE4
-
Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure
NCT01973335 ·Status: COMPLETED ·Phase: PHASE4
-
A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers
NCT01314898 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity
NCT01602861 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
NCT01687699 ·Status: COMPLETED ·Phase: PHASE4